Modulation of cardiometabolic risk and CardioRenal syndrome by oral vitamin D3 supplementation in Black and White Southern Sahara residents with chronic kidney disease Stage 3: focus on racial and ethnic disparities

Modulation of cardiometabolic risk and CardioRenal syndrome by oral vitamin D3 supplementation in Black and White Southern Sahara residents with chronic kidney disease Stage 3: focus on racial and ethnic disparities

Objectives Several studies have shown that cholecalciferol supplementation (25OHD-S) in chronic kidney disease (CKD) improves kidney injury by reducing fibrosis-related vascular calcification and declining apoptosis-linked nephron damage.Methods The oral 25OHD-S was evaluated in 60,000 IU/month/36 w...

Full description

Bibliographic Details
Main Authors: Asma Bouazza, Amina Tahar, Samir AitAbderrhmane, Messaoud Saidani, Elhadj-Ahmed Koceir
Format: Article
Language:English
Published: Taylor & Francis Group 2022-12-01
Series:Renal Failure
Subjects:
Chronic kidney disease
racial and ethnicity
vitamin D
SHPT
cardiometabolic
cardiorenal
Online Access:https://www.tandfonline.com/doi/10.1080/0886022X.2022.2106244

Similar Items

Similar Items